Correction: The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
暂无分享,去创建一个
Jun S. Wei | T. Triche | A. Llombart‐Bosch | S. Sindiri | D. Wai | P. Picci | T. Waldman | Xinyu Wen | D. Solomon | Jung‐Sik Kim | A. Brohl | M. Horwitz | A. Horvai | M. Miettinen | Young-Hwa Song | Wendy Chang | Jianjun Wang | R. Patidar | L. Hurd | Li Chen | J. Shern | Hongling Liao | J. Gerard | I. Machado | D. Catchpool | J. Antônio | L. Guerrero | Javed Khan | A. Llombart-Bosch | Sivasish Sindiri | Laura Hurd
[1] Jun S. Wei,et al. The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation , 2014, PLoS genetics.
[2] M. Nikiforova,et al. ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer , 2014, Cancer.
[3] G. Getz,et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. , 2014, Cancer discovery.
[4] Heather L. Mulder,et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. , 2013, Cancer cell.
[5] M. Rubin,et al. Frequent truncating mutations of STAG2 in bladder cancer , 2013, Nature Genetics.
[6] A. Valencia,et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy , 2013, Nature Genetics.
[7] N. Yoo,et al. Frameshift mutations of chromosome cohesion-related genes SGOL1 and PDS5B in gastric and colorectal cancers with high microsatellite instability. , 2013, Human pathology.
[8] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[9] E Mardis,et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes , 2013, Leukemia.
[10] R. Siebert,et al. High‐resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors , 2013, Genes, chromosomes & cancer.
[11] Masao Nagasaki,et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms , 2012, Nature Genetics.
[12] Kristian Cibulskis,et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.
[13] D. Pisano,et al. The specific contributions of cohesin-SA1 to cohesion and gene expression , 2012, Cell cycle.
[14] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[15] C. Antonescu,et al. High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomas , 2012, Genes, chromosomes & cancer.
[16] P. Hieter,et al. Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators , 2012, PLoS genetics.
[17] D. Zwijnenburg,et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.
[18] Matthew W. Wilson,et al. A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.
[19] Hongtao Yu,et al. Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer , 2011, Science.
[20] S. Salzberg,et al. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts , 2011, Genome Biology.
[21] S. Lessnick,et al. Promiscuous partnerships in Ewing's sarcoma. , 2011, Cancer genetics.
[22] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[23] A. Llombart‐Bosch,et al. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors , 2011, International journal of cancer.
[24] Jonathan W. Pillow,et al. POSTER PRESENTATION Open Access , 2013 .
[25] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[26] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[27] B. Perez-Ordonez,et al. Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity , 2010, The American journal of surgical pathology.
[28] Robert B. Hartlage,et al. This PDF file includes: Materials and Methods , 2009 .
[29] K. Rothkamm,et al. Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin , 2009, Nucleic acids research.
[30] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[31] H. Tanke,et al. The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology , 2009, Clinical Cancer Research.
[32] Samuel Kaski,et al. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors , 2009, BMC Cancer.
[33] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[34] M. Goodman,et al. Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades: Surveillance Epidemiology and End Results Data , 2008, Journal of pediatric hematology/oncology.
[35] R. Malekzadeh,et al. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma , 2007, Oncogene.
[36] S. Burchill,et al. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT , 2007, British Journal of Cancer.
[37] J. Khan,et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. , 2007, The Journal of molecular diagnostics : JMD.
[38] T. Eisen,et al. Variants in the GH-IGF axis confer susceptibility to lung cancer. , 2006, Genome research.
[39] D. Hawkins,et al. Survival after recurrence of Ewing's sarcoma family of tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] F. Couch,et al. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer , 2005, Oncogene.
[41] M. Ladanyi,et al. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] P. Sorensen,et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. , 2002, Cancer cell.
[43] P. Sorensen,et al. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. , 2002, Cancer research.
[44] A. Llombart‐Bosch,et al. Molecular Analysis of the 9p21 Locus and p53 Genes in Ewing Family Tumors , 2001, Laboratory Investigation.
[45] S. Chi,et al. P53 mutations in Ewing's sarcoma. , 2001, Oncology reports.
[46] G. Wei,et al. Prognostic impact of INK4A deletion in Ewing sarcoma , 2000, Cancer.
[47] Y. Kaneko,et al. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. , 2000, Cancer genetics and cytogenetics.
[48] Yusuke Nakamura,et al. Identification of Rad51 alteration in patients with bilateral breast cancer , 2000, Journal of Human Genetics.
[49] P. Ambros,et al. Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors , 1999, Genes, chromosomes & cancer.
[50] J. Fletcher,et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. , 1998, The American journal of pathology.
[51] P. Sorensen,et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma , 1998, Nature Genetics.
[52] H. Kovar,et al. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors , 1997, Oncogene.
[53] O. Myklebost,et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. , 1997, British Journal of Cancer.
[54] Arndt Borkhardt,et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) , 1997, Oncogene.
[55] M. Stratton,et al. A polymorphic stop codon in BRCA2 , 1996, Nature Genetics.
[56] T. Triche,et al. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.
[57] G. Thomas,et al. p53 mutations in human tumors with chimeric EWS/FLI/1 genes , 1994, International journal of cancer.
[58] R. Hanada,et al. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. , 1993, Cancer research.
[59] H. Kovar,et al. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. , 1993, Oncogene.
[60] J. Thiery,et al. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). , 1988, Cancer genetics and cytogenetics.